Cor.Sync
Developer of a point-of-care system for quantitative measurement of ultrassensitive troponin in whole blood. The platform emphasizes rapid results (about 8 minutes), no sample preparation, on-device and electronic medical record reporting, and AI-assisted interpretation; targeted for triage and emergency use in hospitals.
Industries
Nr. of Employees
small (1-50)
Cor.Sync
Products
Point-of-care ultrassensitive troponin measurement system
A point-of-care system that produces quantitative ultrassensitive troponin results from whole blood without sample preparation, with on-device display, EMR reporting and AI-assisted interpretation; intended for rapid use in triage and emergency settings.
Cor.Sync
A point-of-care system for measuring high-sensitivity troponin in whole blood without sample preparation, providing quantitative results in 8 minutes.
Point-of-care ultrassensitive troponin measurement system
A point-of-care system that produces quantitative ultrassensitive troponin results from whole blood without sample preparation, with on-device display, EMR reporting and AI-assisted interpretation; intended for rapid use in triage and emergency settings.
Cor.Sync
A point-of-care system for measuring high-sensitivity troponin in whole blood without sample preparation, providing quantitative results in 8 minutes.
Expertise Areas
- Point-of-care diagnostics
- Cardiac biomarker testing (troponin)
- Clinical decision support systems
- Assay and sensor development
Key Technologies
- Point-of-care ultrassensitive troponin immunoassay
- Whole-blood quantitative biomarker measurement
- High-specificity sensor technology
- AI-based analytics for clinical decision support
News & Updates
Listed as 'Deeptech do Ano' in Brazil (2025).
Exhibited at BIO International Convention in Boston (2025).
Recognized as DeepTech Pioneer at Hello Tomorrow summit (Paris, 2025).
Winner and global finalist in Empreenda Saúde program (Fundação Everis).
Media coverage discussing the potential market and testing gap in hospitals and the company's goal to increase troponin testing coverage.
Article describing the clinical need for rapid troponin-based diagnosis and delays associated with laboratory-structured testing.
Listed as 'Deeptech do Ano' in Brazil (2025).
Exhibited at BIO International Convention in Boston (2025).
Recognized as DeepTech Pioneer at Hello Tomorrow summit (Paris, 2025).
Winner and global finalist in Empreenda Saúde program (Fundação Everis).
Media coverage discussing the potential market and testing gap in hospitals and the company's goal to increase troponin testing coverage.
Article describing the clinical need for rapid troponin-based diagnosis and delays associated with laboratory-structured testing.